Сравнительная оценка эффективности применения Ксеникала у пациентов с ожирением при различном времени дебюта заболевания
https://doi.org/10.14341/2071-8713-5020
Список литературы
1. Бутрова С.А., Плохая А.А. Лечение ожирения: современные аспекты. РМЖ. 2001; 9:1140-6.
2. Платонов А.Е. Статистический анализ в медицине и биологии: задачи, терминология, логика, компьютерные методы. М.: РАМН, 2000.
3. Савельева Л.В. Современные подходы к лечению ожирения. Врач. 2000;12:12-14.
4. Braddon F.E., Rodgers B., Wadsworth M.E., Davies J.M. Onset of obesity in a 36 year birth cohort study. Br. Med. J (Clin Res Ed). 1986;293: 299-303.
5. Drent M.L., van der Veen E.A. Lipase inhibition: A novel concept in the treatment of obesity. Int. J. Obes. Relat. Metab. Disord. 1993;17:241-244
6. de Ferranti S.D., Gauvreau K., Ludwig D.S., et al. Prevalence of the metabolic syndrome in american adolescents. Findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494 -2497.
7. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
8. Methods for voluntary weight loss and control: NIH Technology Assessment Conference Panel: Consensus Development Conference, 30 March to 1 April, 1992. Ann. Intern. Med. 1993;119:764-770.
9. Mittendorfer B., Ostlund R.E., Patterson B.W., Klein S. Orlistat inhibits dietary cholesterol absorption. Obes. Res. 2001;9:599-604.
10. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., Marks J.S. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003; 289:76-79].
11. Power C., Lake J.K., Cole T.J. Body mass index and height from childhood to adulthood in the 1958 British born cohort. Am. J. Clin. Nutr. 1997;66:1094-101.
12. Serdula M.K., Ivery D., Coates R.J., Freedman D.S., Williamson D.F., Byers T. Do obese children become obese adults? A review of the literature. Prev. Med. 1993;22:167-77
13. Srinivasan S.R., Myers L., and Berenson G.S. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood. The Bogalusa Heart Study. Diabetes. 2002;51:204-209
14. Styne D.M. Childhood and adolescent obesity. Prevalence and significance. Pediatr. Clin. North. Am. 2001;48(4):823-854.
15. Whitaker R.C., Wright J.A., Pepe M.S., et al. Predicting obesity in young adulthood from childhood and parental obesity. N. Engl. J. Med. 1997;337:869-73.
16. World Health Organization: Prevention and Managing the Global Epidemic of Obesity. Report of the WHO Consultation on Obesity. WHO, 1997.
Рецензия
Для цитирования:
Poluboyarinova I.V., Romantsova T.I., Roik O.V. Сравнительная оценка эффективности применения Ксеникала у пациентов с ожирением при различном времени дебюта заболевания. Ожирение и метаболизм. 2007;4(3):33-39. https://doi.org/10.14341/2071-8713-5020
For citation:
, , Sravnitel'naya otsenka effektivnosti primeneniya Ksenikala u patsientov s ozhireniem pri razlichnom vremeni debyuta zabolevaniya. Obesity and metabolism. 2007;4(3):33-39. (In Russ.) https://doi.org/10.14341/2071-8713-5020

Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).